Sang Wook Kim

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

Ashwini M. Londhe, Ki Duk Park, Jeiwon Cho, 2019, Science Advances.

Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists.

In-kyu Lee, Hueng-Sik Choi, Thoudam Debraj Singh, 2016, Journal of medicinal chemistry.

Pharmacokinetic study comparing pure desoxo-narchinol A and nardosinonediol with extracts from Nardostachys jatamansi.

J. Kim, Khong Trong Quan, M. Na, 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia.

Y. Yoon, K. Sung, S. Han, 2018, Clinical therapeutics.

Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment

Y. Jung, Byeong‐Woo Park, Joon Jeong, 2018, Journal of Breast Cancer.

Involvement of protein kinase Cδ in iron chelator-induced IL-8 production in human intestinal epithelial cells

C. Jun, E. Choi, Sang-Hyun Kim, 2007 .